Two Sigma Investments, LP Aldeyra Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 146,759 shares of ALDX stock, worth $702,975. This represents 0.0% of its overall portfolio holdings.

Number of Shares
146,759
Previous 193,115 24.0%
Holding current value
$702,975
Previous $639,000 23.79%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.19 - $6.32 $147,875 - $292,969
-46,356 Reduced 24.0%
146,759 $791,000
Q2 2024

Aug 14, 2024
SELL
$3.25 - $4.72 $149,009 - $216,407
-45,849 Reduced 19.19%
193,115 $639,000
Q1 2024

May 15, 2024
BUY
$2.77 - $4.22 $103,661 - $157,925
37,423 Added 18.57%
238,964 $781,000
Q4 2023

Feb 14, 2024
SELL
$1.47 - $6.06 $96,698 - $398,632
-65,781 Reduced 24.61%
201,541 $707,000
Q3 2023

Nov 14, 2023
BUY
$6.11 - $8.16 $831,094 - $1.11 Million
136,022 Added 103.6%
267,322 $1.79 Million
Q2 2023

Aug 14, 2023
SELL
$7.11 - $11.89 $634,212 - $1.06 Million
-89,200 Reduced 40.45%
131,300 $1.1 Million
Q1 2023

May 15, 2023
SELL
$5.77 - $9.93 $1.33 Million - $2.29 Million
-230,187 Reduced 51.07%
220,500 $2.19 Million
Q4 2022

Feb 14, 2023
SELL
$5.08 - $7.09 $664,220 - $927,031
-130,752 Reduced 22.49%
450,687 $3.14 Million
Q3 2022

Nov 14, 2022
SELL
$3.8 - $7.74 $93,590 - $190,628
-24,629 Reduced 4.06%
581,439 $3.11 Million
Q2 2022

Aug 15, 2022
BUY
$2.43 - $4.85 $639,529 - $1.28 Million
263,181 Added 76.75%
606,068 $2.42 Million
Q1 2022

May 16, 2022
SELL
$3.25 - $5.17 $1.09 Million - $1.73 Million
-334,185 Reduced 49.36%
342,887 $1.52 Million
Q4 2021

Feb 14, 2022
SELL
$3.5 - $9.63 $417,035 - $1.15 Million
-119,153 Reduced 14.96%
677,072 $2.71 Million
Q3 2021

Nov 15, 2021
SELL
$7.94 - $11.31 $2.66 Million - $3.78 Million
-334,509 Reduced 29.58%
796,225 $6.99 Million
Q2 2021

Aug 16, 2021
BUY
$10.44 - $14.85 $2.6 Million - $3.69 Million
248,772 Added 28.21%
1,130,734 $12.8 Million
Q1 2021

May 17, 2021
BUY
$6.53 - $14.42 $1.41 Million - $3.11 Million
215,593 Added 32.35%
881,962 $10.5 Million
Q4 2020

Feb 16, 2021
SELL
$6.31 - $8.13 $21,864 - $28,170
-3,465 Reduced 0.52%
666,369 $4.57 Million
Q3 2020

Nov 16, 2020
BUY
$4.0 - $7.53 $1.98 Million - $3.74 Million
496,101 Added 285.55%
669,834 $4.96 Million
Q2 2020

Aug 14, 2020
BUY
$1.97 - $5.05 $187,490 - $480,623
95,173 Added 121.15%
173,733 $724,000
Q1 2020

May 15, 2020
BUY
$1.62 - $6.4 $127,267 - $502,784
78,560 New
78,560 $194,000
Q4 2018

Feb 14, 2019
SELL
$7.26 - $13.29 $297,144 - $543,946
-40,929 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$6.8 - $14.35 $278,317 - $587,331
40,929 New
40,929 $565,000

Others Institutions Holding ALDX

# of Institutions
117
Shares Held
36.4M
Call Options Held
196K
Put Options Held
142K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $279M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email